Aranda Richard — SEC Form 4 filings

SEC reporting owner CIK 1867872. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-20.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-19 to 2026-03-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Gossamer Bio, Inc. (GOSS)Chief Medical Officer62 legs · 5,926 sh · $6,60228

Form 4 filings — Aranda Richard

FiledFormIssuerReported transactionsSource
2026-03-204Gossamer Bio, Inc. (GOSS)Disposition to issuer (D): 562,500 (derivative) · Disposition to issuer (D): 572,000 (derivative) · Disposition to issuer (D): 487,500 (derivative) · Disposition to issuer (D): 162,500 (derivative) · Disposition to issuer (D): 157,500 (derivative) · Disposition to issuer (D): 157,500 (derivative) · +18 moreEDGAR
2026-01-054Gossamer Bio, Inc. (GOSS)Grant/award (A): 93,750 @ $0 · Grant/award (A): 562,500 (derivative) @ $0EDGAR
2025-10-024Gossamer Bio, Inc. (GOSS)Grant/award (A): 162,500 @ $0EDGAR
2025-03-064Gossamer Bio, Inc. (GOSS)Grant/award (A): 572,000 (derivative) @ $0EDGAR
2024-06-254Gossamer Bio, Inc. (GOSS)Sale (S): 1,908 @ $0.66EDGAR
2024-03-194Gossamer Bio, Inc. (GOSS)Sale (S): 4,018 @ $1.33EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1867872 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →